Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RNS® System Responsive Thalamic Stimulation for Primary Generalized Seizures (NAUTILUS) Study

NCT05147571 is registered in ClinicalTrials.gov with NeuroPace as lead sponsor.

NCT NCT05147571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05147571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RNS® System Responsive Thalamic Stimulation for Primary Generalized Seizures (NAUTILUS) Study
Lead sponsor
NeuroPace
Phase
Not applicable
Overall status
Completed
Start date
August 9, 2022
Completion date
March 31, 2026
Enrollment
100 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, generalized tonic clonic seizure, idiopathic generalized epilepsy